Soluble receptors for tumor necrosis factor-alpha (TNF-R p55 and TNF-R p75) in familial combined hyperlipidemia.

Atherosclerosis

Laboratory for Molecular Metabolism and Endocrinology/UNS 50, Department of Internal Medicine, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, PO Box 616, 6200 MD, Maastricht, The Netherlands.

Published: November 2000

We investigated the potential role of the 75 kD receptor for tumor necrosis factor-alpha (TNF-alpha) (TNFRSF1B, located on chromosome 1 band p36.2) as a modifier gene in familial combined hyperlipidemia (FCH), based on previous linkage and association data. Age-corrected values for the soluble (s) extracellular domain of TNF-R p75 were lower in 156 well-characterized hyperlipidemic (HL) FCH relatives than in 168 normolipidemic (NL) relatives (P<0.01). Plasma concentrations of the soluble domain of the 55 kD receptor (sTNF-R p55, the other TNF-alpha receptor) did not differ between HL and NL relatives. In conditional logistic regression analysis, plasma sTNF-R p75 concentration was the only non-lipid variable that contributed significantly to prediction of affected FCH status (regression coefficient=-0.413, P=0.01). The present findings have potentially important diagnostic and therapeutic implications in FCH.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0021-9150(00)00375-0DOI Listing

Publication Analysis

Top Keywords

tumor necrosis
8
necrosis factor-alpha
8
tnf-r p75
8
familial combined
8
combined hyperlipidemia
8
soluble receptors
4
receptors tumor
4
factor-alpha tnf-r
4
tnf-r p55
4
p55 tnf-r
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!